Nu Skin Enterprises (NUS) Misses Q2 EPS by 4c; offers guidance

Nu Skin Enterprises (NYSE: NUS) reported Q2 EPS of $0.21, $0.04 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $386.1 million versus the consensus estimate of $376.67 million.

GUIDANCE:

Nu Skin Enterprises sees Q3 2025 EPS of $0.25-$0.35, versus the consensus of $0.29. Nu Skin Enterprises sees Q3 2025 revenue of $360-390 million, versus the consensus of $366.1 million.

Nu Skin Enterprises sees FY2025 EPS of $3.05-$3.25, versus the consensus of $0.99. Nu Skin Enterprises sees FY2025 revenue of $1.48-1.55 billion, versus the consensus of $1.483 billion.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.

You May Also Be Interested In

• INVO Fertility (IVF) Tops Q2 EPS by 105c
• Trump threatens to bomb Oman over Iran stance
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c